ArticleCureus2025
Effectiveness of Cucumis sativus L. Supplementation on Mild to Moderate Joint Pain: A Randomized, Double-Blind, Placebo-Controlled Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundJoint pain affects millions worldwide, impairing mobility and quality of life, and is a focus in management and therapy. Preliminary research found that the cucumber extract
objectiveThis study aimed to examine the effectiveness of a standardized powder (>1% idoBR1) of
methodsIn this Consolidated Standards of Reporting Trials (CONSORT)-compliant, double-blind, placebo-controlled trial, 80 adults (mean age = 50.10) were randomized to either the
resultsImprovements in all the pain outcomes over time for the CG were evidenced, with larger improvements in the CG compared to PG for the WOMAC, Brief Pain Inventory, and Pain Disability Index. Significant improvements in the WOMAC for the CG were evidenced on day 30 and day 60. From baseline to day 60, the CG showed individual percent changes of 31.79%, 10.07%, and 32.39% for the WOMAC, Lequesne Functional Index, and Pain Disability Index, while the PG experienced declines of 14.30%, 9.56%, and 14.96%, respectively, for the same measures.
conclusion
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.